Valuation: Embracing Future Holdings Limited

Market Cap 53.74M 41.99M 37.43M 34.68M 31.53M 59.16M 3.98B 60.14M 416M 164M 2.08B 158M 154M 6.65B P/E 2024
-8.18x
P/E 2025 -22.5x
Enterprise Value 55.59M 43.44M 38.73M 35.87M 32.62M 61.21M 4.12B 62.21M 430M 169M 2.15B 163M 160M 6.88B EV / Sales 2024
58.8x
EV / Sales 2025 17.5x
Free-Float
44.94%
Yield 2024 *
-
Yield 2025 -
1 week-6.06%
Current month-8.82%
1 month-13.89%
3 months-20.51%
6 months-43.64%
Current year-40.38%
1 week 0.03
Extreme 0.03
0.03
1 month 0.03
Extreme 0.03
0.04
Current year 0.03
Extreme 0.03
0.09
1 year 0.02
Extreme 0.021
0.09
3 years 0.01
Extreme 0.008
0.09
5 years 0.01
Extreme 0.008
0.22
10 years 0.01
Extreme 0.008
0.88
Manager TitleAgeSince
President 46 30/04/2024
Comptroller/Controller/Auditor 44 01/07/2024
Corporate Secretary - -
Director TitleAgeSince
Director/Board Member 64 14/06/2021
Director/Board Member 55 31/03/2023
Director/Board Member 70 27/11/2023
Date Insider Type Main position Quantity % Market Cap. Importance
4/30/21 A Exercice

Chairman

330,000 0.1250%
8/19/20 A Free

Chairman

1,130,000 0.4340%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-6.06%+29.17%+138.46% 41.99M
-1.54%+2.59%+26.06%+44.65% 251B
-2.01%+1.46%+7.35%+8.26% 158B
+1.52%+1.30%-2.90%+58.41% 153B
+1.49%+2.76%-54.60%-10.88% 65.29B
+0.35%+3.48%-14.60%-10.20% 51.23B
+2.08%+7.08%+11.66%+56.70% 51.29B
+0.72%+0.96%+16.85%+26.26% 50.27B
-1.77%-0.83%+19.72%+55.15% 47.9B
-0.61%+0.50%+29.79%+72.10% 42.67B
Average -0.30%+0.82%+6.85%+43.89% 87.07B
Weighted average by Cap. -0.66%+2.64%+7.59%+34.66%

Financials

2024 2025
Net sales 858K 671K 598K 554K 503K 945K 63.57M 960K 6.64M 2.61M 33.23M 2.52M 2.46M 106M 5.26M 4.11M 3.66M 3.39M 3.09M 5.79M 390M 5.89M 40.72M 16.01M 204M 15.43M 15.1M 651M
Net income -3.43M -2.68M -2.39M -2.22M -2.01M -3.78M -254M -3.84M -26.58M -10.45M -133M -10.07M -9.86M -425M -3.96M -3.1M -2.76M -2.56M -2.32M -4.36M -294M -4.43M -30.67M -12.06M -153M -11.62M -11.37M -490M
Net Debt 1.46M 1.14M 1.01M 939K 854K 1.6M 108M 1.63M 11.26M 4.43M 56.34M 4.27M 4.18M 180M 1.86M 1.45M 1.29M 1.2M 1.09M 2.04M 138M 2.08M 14.37M 5.65M 71.87M 5.44M 5.33M 230M
Projected Income Statement - Annual - Embracing Future Holdings Limited
Logo Embracing Future Holdings Limited
Embracing Future Holdings Ltd, formerly Biolidics Limited, is a precision medicine medical technology company. Its principal activities are technology development, technology transfer, selling and distribution of biomedical technology, life and medicine science related products and services; provision of laboratory services and investment holding. Its segments are Cancer, Infectious diseases, Laboratory services, and Corporate segments. Its Cancer and infectious diseases segments involve identifying and assessing potential collaboration partners, technology, products and services, product development, innovation and improvement and the management of global distributorship networks and direct customers in the cancer field, and the infectious diseases field. The Laboratory services segment involves business, operation, and provision of laboratory services to customers. The laboratory has regulatory approval from Singapore’s Ministry of Health for testing for COVID-19 in Singapore.
Employees
-
Date Price Change Volume
20/10/26 SGD 0.0310 0.00% 603,000
19/10/26 SGD 0.0310 -3.13% 327,000
16/10/26 SGD 0.0320 +3.23% 1,256,900
15/10/26 SGD 0.0310 -6.06% 2,035,100
14/10/26 SGD 0.0330 0.00% 2,407,800